Average Co-Inventor Count = 9.91
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Astrazeneca Ab (14 from 1,500 patents)
2. Astex Therapeutics Limited (1 from 123 patents)
3. Arcturum Real Estate Ab (1 from 1 patent)
4. Acturum Real Estate Ab (1 from 1 patent)
5. Gesynta Pharma Ab (0 patent)
16 patents:
1. 10815199 - NMDA antagonist prodrugs
2. 10231967 - Compounds and their use as BACE inhibitors
3. 10227296 - Bis(sulfonamide) derivatives and their use as mPGES inhibitors
4. 10207994 - NMDA antagonist prodrugs
5. 10081614 - Bis(sulfonamide) derivatives and their use as mPGES inhibitors
6. 9918985 - Compounds and their use as BACE inhibitors
7. 9822075 - NMDA antagonist prodrugs
8. 9248129 - Compounds and their use as BACE inhibitors
9. 8865911 - Compounds and their use as BACE inhibitors
10. 8415483 - Compounds and their use as BACE inhibitors
11. 8158785 - 5,7-disubstituted[1.3]thiazolo [4,5-D] pyrimidin-2(3H)-amine derivatives and their use in therapy
12. 7960395 - 5,7-disubstituted thiazolo[4,5-d]pyrimidines for the selective inhibition of chemokine receptors
13. 7855213 - Compounds
14. 7585881 - Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
15. 7576077 - Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists